Why the study?
What is the durability of tricuspid valve bioprostheses in patients with congenital heart disease?
What is the durability of tricuspid valve bioprostheses in patients with congenital heart disease?
Tricuspid valve bioprostheses show rapid dysfunction in congenital heart disease patients, especially those under 16 years of age where most fail within 5 years.
No takes yet. Share an insight, caveat, or question.
Early dysfunction in young congenital patients warrants caution in valve choice; leaves open optimal strategies pending prospective trials.
Burri et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: